Clinical trial
A Comparative Study of the Week 12 Antiviral Efficacy and Safety of Switching to Entecavir vs. Continuing Adefovir Treatment in Adults With Chronic Hepatitis B and Suboptimal Response to Adefovir
NCT00718887 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Study of the Week 12 Antiviral Efficacy and Safety of Switching to Entecavir vs. Continuing Adefovir Treatment in Adults With Chronic Hepatitis B and Suboptimal Response to Adefovir
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- January 31, 2011
- Enrollment
- 228 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.